Molecular docking, synthesis and anticonvulsant activity of some novel 3-(2-substituted)-4-oxothiazolidine-3-yl)-2-phenylquinazoline-4(3H)-ones
作者:Sampada S. Jangam、Sagar B. Wankhede、Sohan S. Chitlange
DOI:10.1007/s11164-018-3612-9
日期:2019.2
animal protection from 83 to 100%. The results were compared with the standard. All compounds exhibited good binding energies ranging from − 5.15 to − 6.13 kcal/mol with sodium channel IIA inactivation gate (PDB ID: 1BYY) in molecular docking study; amongst them, 3d has shown significant binding energy of − 6.13 kcal/mol. The obtained result showed that biologically active compounds could be used as a
由于喹唑啉酮和噻唑烷酮具有广泛的生物学活性,因此在文学中已被广泛提及,因此它们的相关毒理学特性不容忽视。因此,本研究的目的是合成3-(2-取代)-4-氧噻唑烷-3-基)-2-苯基喹唑啉-4(3 H)-ones (3a – 3k),并将其作为抗惊厥药进行评估。合成了一系列新颖的3a - 3k,并在元素和光谱分析的基础上阐明了它们的结构。合成了包含喹唑啉酮和噻唑烷酮部分的混合支架以获得标题化合物及其体内通过最大电休克(MES)诱发的惊厥模型以25 mg / kg体重的剂量进行抗惊厥活动。发现六种化合物3b,3c,3d,3e,3f和3i具有显着的抗惊厥活性,其后肢补剂的持续时间为13.117到16.450 s,动物保护作用为83%到100%。将结果与标准进行比较。在分子对接研究中,所有化合物在钠通道IIA灭活门(PDB ID:1BYY)下均表现出良好的结合能,范围为− 5.15至− 6.13 kcal